PATENT CLAIM ANALYSIS

Application Number: 15771958
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "04400A"]

Abstract:
The purpose of the present invention is to obtain novel therapeutic drugs for malignant tumors, methods for producing a stem cell, or DNA damage-ameliorating agents, etc., wherein a HAT1 and KAT8 inhibitor is used; a kit containing a HAT1 inhibitor and a KAT8 inhibitor may be used; a composition comprising a HAT1 inhibitor, wherein the HAT1 inhibitor is used in combination with a KAT8 inhibitor, may be used; or a composition comprising a KAT8 inhibitor, wherein the KAT8 inhibitor is used in combination with a HAT1 inhibitor, may be used.

Claim (Index 39):
The production method according to  claim 35 , wherein the inhibition is to inhibit expression and function of HAT1 and KAT8 genes.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 2.37209
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13809880', '13809882', '15569559', '14376408', '09841744']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7570965710451057
- 35 USC 102 Novelty (BERT): 0.509414135001835
- Combined Prediction Score: 0.7323283274407786
- Mean Citation Score: 190.56531
- Max Citation Score: 210.38239
- Similarity Product: 121.82969852841671

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test